NET PROFIT (x1000 DKK)
PCI Biotech Holding ASA
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
106
|
254
|
2,349 |
Earnings before taxes |
-13,470
|
-38,921
|
-65,905 |
Total assets |
29,207
|
44,846
|
101,386 |
Current assets |
29,010
|
44,335
|
95,675 |
Current liabilities |
3,298
|
4,064
|
15,591 |
Equity capital |
25,886
|
40,551
|
84,845 |
- share capital |
742
|
79,107
|
83,492 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
88.6%
|
90.4%
|
83.7% |
Turnover per employee | |||
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-45.8%
|
-86.2%
|
-62.7% |
Current ratio |
879.6%
|
1090.9%
|
613.7% |
Return on equity (ROE) |
-52.0%
|
-96.0%
|
-77.7% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.